SEC and FDA team up to monitor disclosures
New initiative increases pressure on life science companies to disclose clinical trial results accurately.
Special to The National Law Journal, The National Law Journal
Along with the opportunities provided by public company life, there are obligations imposed by the federal securities laws that life science companies must be prepared to meet
Read more: http://www.nationallawjournal.com/id=900005408600/SEC-and-FDA-team-up-to-monitor-disclosures#ixzz3qXGSbhrB
No comments:
Post a Comment